Thyroid hormone replacement: current status and challenges

Bibliography

• Tunbridge WM, Evered DC, Hall R, The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, Serum TSH. T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99
   PubMed Web of Science ®Google Scholar
• Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803
   PubMed Web of Science ®Google Scholar
• Duntas LH. Thyroid disease and lipids. Thyroid 2002;12:287-93
   PubMed Web of Science ®Google Scholar
• Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131
   PubMed Web of Science ®Google Scholar
• Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998;158:1413-18
   PubMedGoogle Scholar
• Fliers E, Wiersinga WM. Myxedema coma. Rev Endocr Metab Disord 2003;4:137-41
   PubMed Web of Science ®Google Scholar
• Parle JV, Franklyn JA, Cross KW, Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993;43:107-9
   PubMed Web of Science ®Google Scholar
• De Whalley P. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995;45:93-5
   PubMed Web of Science ®Google Scholar
• Diez JJ. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci 2002;57:M315-20
   Web of Science ®Google Scholar
• Somwaru LL, Arnold AM, Joshi N, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009;94:1342-5
   PubMed Web of Science ®Google Scholar
• Flynn RW, Bonellie SR, Jung RT, Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010;95:186-93
   PubMed Web of Science ®Google Scholar
• Hannemann A, Friedrich N, Haring R, Thyroid function tests in patients taking thyroid medication in Germany: results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes 2010;3:227
   PubMedGoogle Scholar
• Okosieme OE, Belludi G, Spittle K, Adequacy of thyroid hormone replacement in a general population. QJM 2011;104:395-401
   PubMed Web of Science ®Google Scholar
• Saravanan P, Chau WF, Roberts N, Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57:577-85
   PubMed Web of Science ®Google Scholar
• Slater SD. The discovery of thyroid replacement therapy. JLL Bulletin: Commentaries on the history of treatment evaluation. 2010. Available from: http://www.jameslindlibrary.org/illustrating/articles/the-discovery-of-thyroid-replacement-therapy.pdf [Last accessed 20 April 2011]
   Google Scholar
• Sawin CT. The invention of thyroid therapy in the late nineteenth century. Endocrinologist 2001;11:1-3
   Google Scholar
• Murray GR. Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. BMJ 1891;2:796-7
   PubMedGoogle Scholar
• Bettencourt R, Serrano JA. Un cas de myxoedeme traite par la greffe hypodermique du corps thyroide d'un mouton. La Semaine Med 1890;10:294
   Google Scholar
• Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994;15:788-830
   PubMed Web of Science ®Google Scholar
• Lazarus JH, Parkes AB, Premawardhana LD. Postpartum thyroiditis. Autoimmunity 2002;35:169-73
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43:55-68
   PubMed Web of Science ®Google Scholar
• Huber G, Staub JJ, Meier C, Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002;87:3221-6
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 2004;89:4890-7
   PubMed Web of Science ®Google Scholar
• Rodondi N, Den Elzen WP, Bauer DC, Thyroid studies collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365-74
   PubMed Web of Science ®Google Scholar
• Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000;85:2993-3001
   PubMed Web of Science ®Google Scholar
• Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007;3:CD003419
   Google Scholar
• Casey BM, Dashe JS, Wells CE, Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-45
   PubMed Web of Science ®Google Scholar
• Haddow JE, Palomaki GE, Allan WC, Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214
   PubMed Web of Science ®Google Scholar
• Lima N, Knobel M, Cavaliere H, Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997;7:691-7
   PubMed Web of Science ®Google Scholar
• Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002;87:4154-9
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Sarlis NJ, Litofsky D, Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006;16:1229-42
   PubMed Web of Science ®Google Scholar
• Pujol P, Daures JP, Nsakala N, Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81:4318-23
   PubMed Web of Science ®Google Scholar
• Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010;20:135-46
   PubMed Web of Science ®Google Scholar
• Toft AD. Thyroxine therapy. N Engl J Med 1994;331:174-80
   PubMed Web of Science ®Google Scholar
• Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502
   PubMed Web of Science ®Google Scholar
• Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab 2009;23:781-92
   PubMed Web of Science ®Google Scholar
• Roos A, Linn-Rasker SP, Van Domburg RT, The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005;165:1714-20
   PubMed Web of Science ®Google Scholar
• British Thyroid Association/Association of Clinical Biochemistry Guidelines 2006. Available from: www.british-thyroid-association.org/info-for-patients/Docs/TFT_guideline_ final_ version_ July_2006.pdf [Last accessed 20 April 2011]
   Google Scholar
• Vaidya B, Pearce SH. Management of hypothyroidism in adults. BMJ 2008;337:a801
   PubMedGoogle Scholar
• Walsh JP, Ward LC, Burke V, Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab 2006;91:2624-30
   PubMed Web of Science ®Google Scholar
• Wekking EM, Appelhof BC, Fliers E, Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 2005;153:747-53
   PubMed Web of Science ®Google Scholar
• Saravanan P, Visser TJ, Dayan CM. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab 2006;91:3389-93
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Marx H, Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin Pharmacothe 2008;9:2281-93
   PubMed Web of Science ®Google Scholar
• Abalovich M, Amino N, Barbour LA, Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007;92(Suppl 8):S1-47
   Web of Science ®Google Scholar
• Lania A, Persani L, Beck-Peccoz P. Central hypothyroidism. Pituitary 2008;11:181-6
   PubMed Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, Guidelines committee, national academy of clinical biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126
   PubMed Web of Science ®Google Scholar
• Sawin CT, Geller A, Wolf PA, Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52
   PubMed Web of Science ®Google Scholar
• Cappola AR, Fried LP, Arnold AM, Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033-41
   PubMed Web of Science ®Google Scholar
• Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;13:265-9
   Google Scholar
• Paul TL, Kerrigan J, Kelly AM, Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988;259:3137-41
   PubMed Web of Science ®Google Scholar
• Bauer DC, Ettinger B, Nevitt MC, Stone KL. Study of osteoporotic fractures research group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134:561-8
   PubMed Web of Science ®Google Scholar
• Turner RM, Camacho X, Fischer HD, Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ 2011;342:d2238
   PubMedGoogle Scholar
• Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88:2438-44
   PubMed Web of Science ®Google Scholar
• Obuobie K, Smith J, Evans LM, Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 2002;87:4662-6
   PubMed Web of Science ®Google Scholar
• Owen PJ, Sabit R, Lazarus JH. Thyroid disease and vascular function. Thyroid 2007;17:519-24
   PubMed Web of Science ®Google Scholar
• Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol (Oxf) 2009;70:671-3
   PubMed Web of Science ®Google Scholar
• Santini F, Pinchera A, Marsili A, Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 2005;90:124-7
   PubMed Web of Science ®Google Scholar
• Bolk N, Visser TJ, Nijman J, Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med 2010;170:1996-2003
   PubMed Web of Science ®Google Scholar
• Bach-Huynh TG, Nayak B, Loh J, Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab 2009;94:3905-12
   PubMed Web of Science ®Google Scholar
• Taylor J, Williams BO, Frater J, Twice-weekly dosing for thyroxine replacement in elderly patients with primary hypothyroidism. J Int Med Res 1994;22:273-7
   PubMed Web of Science ®Google Scholar
• Grebe SK, Cooke RR, Ford HC, Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 1997;82:870-5
   PubMed Web of Science ®Google Scholar
• Crilly M. Thyroxine adherence in primary hypothyroidism. Lancet 2004;363:1558
   PubMed Web of Science ®Google Scholar
• Bagattoli RM, Vaisman M, Lima JS, Ward LS. Estudo de adesao ao tratamento do hipotiroidismo. Arq Bras Endocrinol Metabol 2000;44:483-7
   Google Scholar
• Crilly M, Esmail A. Randomised controlled trial of a hypothyroid educational booklet to improve thyroxine adherence. Br J Gen Pract 2005;55:362-8
   PubMed Web of Science ®Google Scholar
• Ward LS. The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism. Arq Bras Endocrinol Metabol 2010;54:435-42
   PubMed Web of Science ®Google Scholar
• McDermott JH, Coss A, Walsh CH. Celiac disease presenting as resistant hypothyroidism. Thyroid 2005;15:386-8
   PubMed Web of Science ®Google Scholar
• Checchi S, Montanaro A, Ciuoli C, Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid 2010;20:1385-9
   PubMed Web of Science ®Google Scholar
• Centanni M, Gargano L, Canettieri G, Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787-95
   PubMed Web of Science ®Google Scholar
• Checchi S, Montanaro A, Pasqui L, L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 2008;93:465-9
   PubMed Web of Science ®Google Scholar
• Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract 2010;64:1130-9
   PubMed Web of Science ®Google Scholar
• Illouz F, Laboureau-Soares S, Dubois S, Tyrosine kinase inhibitors and modifications of thyroid function tests: a review. Eur J Endocrinol 2009;160:331-6
   PubMed Web of Science ®Google Scholar
• Eisenberg M, Distefano JJ. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid 2009;19:103-10
   PubMed Web of Science ®Google Scholar
• Roberts ND. Psychological problems in thyroid disease. Br Thyroid Found Newsl 1996;18:3
   Google Scholar
• Escobar-Morreale HF, Obregon MJ, Escobar Del Rey F, Morreale De Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest 1995;96:2828-38
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Escobar Del Rey F, Morreale De Escobar G. Review: treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005;90:4946-54
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008;299:769-77
   PubMed Web of Science ®Google Scholar
• Kaplan MM, Sarne DH, Schneider AB. Editorial: in search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clin Endocrinol Metab 2003;88:4540-2
   PubMed Web of Science ®Google Scholar
• Laurberg P. Patients on appropriate T(4) replacement are as content as they would be on any thyroid hormone. J Clin Endocrinol Metab 2004;89:2507
   PubMed Web of Science ®Google Scholar
• Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. BMJ 1970;4:145-8
   PubMedGoogle Scholar
• Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Jakubonien N, Jurkevicius R, Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 2002;18:129-33
   PubMed Web of Science ®Google Scholar
• Walsh JP, Shiels L, Lim EM, Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003;88:4543-50
   PubMed Web of Science ®Google Scholar
• Siegmund W, Spieker K, Weike AI, Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 2004;60:750-7
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005;142:412-24
   PubMed Web of Science ®Google Scholar
• Rodriguez T, Lavis VR, Meininger JC, Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 2005;11:223-33
   PubMedGoogle Scholar
• Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 2003;290:2952-8
   PubMed Web of Science ®Google Scholar
• Sawka AM, Gerstein HC, Marriott MJ, Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4551-5
   PubMed Web of Science ®Google Scholar
• Appelhof BC, Fliers E, Wekking EM, Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism:a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005;90:2666-74
   PubMed Web of Science ®Google Scholar
• Levitt JA, Silverberg J. T4 plus T3 for hypothyroidism: a double-blind comparison with usual T4. Proceedings of the 74th Annual Meeting of the American Thyroid Association, 10 – 13 October 2002, Los Angeles, CA, USA
   Google Scholar
• Saravanan P, Simmons DJ, Greenwood R, Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005;90:805-12
   PubMed Web of Science ®Google Scholar
• Nygaard B, Jensen EW, Kvetny J, Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol 2009;161:895-902
   PubMed Web of Science ®Google Scholar
• Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics 2007;48:379-84
   PubMed Web of Science ®Google Scholar
• Grozinsky-Glasberg S, Fraser A, Nahshoni E, Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006;91:2592-9
   PubMed Web of Science ®Google Scholar
• Cooper DS. Combined T4 and T3 therapy – back to the drawing board. JAMA 2003;290:3002-4
   PubMed Web of Science ®Google Scholar
• Wiersinga WM. Do we need still more trials on T4 and T3 combination therapy in hypothyroidism? Eur J Endocrinol 2009;161:955-9
   PubMed Web of Science ®Google Scholar
• Klein I. T3 and T4: are we missing half the picture? Clin Cornerstone 2005;7(Suppl 2):S5-8
   PubMedGoogle Scholar
• Hennemann G, Docter R, Visser TJ, Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004;14:271-5
   PubMed Web of Science ®Google Scholar
• Dayan CM, Panicker V. Novel insights into thyroid hormones from the study of common genetic variation. Nat Rev Endocrinol 2009;5:211-18
   PubMed Web of Science ®Google Scholar
• Panicker V, Saravanan P, Vaidya B, Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 2009;94:1623-9
   PubMed Web of Science ®Google Scholar
• Appelhof BC, Peeters RP, Wiersinga WM, Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy. J Clin Endocrinol Metab 2005;90:6296-9
   PubMed Web of Science ®Google Scholar
• Torlontano M, Durante C, Torrente I, Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab 2008;93:910-13
   PubMed Web of Science ®Google Scholar
• Heemstra KA, Hoftijzer HC, Van Der Deure WM, Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 2009;71:279-83
   PubMed Web of Science ®Google Scholar
• Van Der Deure WM, Appelhof BC, Peeters RP, Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin Endocrinol (Oxf) 2008;69:804-11
   PubMed Web of Science ®Google Scholar
• Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002;87:1068-72
   PubMed Web of Science ®Google Scholar
• Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010;95:496-502
   PubMed Web of Science ®Google Scholar